202 related articles for article (PubMed ID: 26075077)
1. Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis.
Zhu N; Zhang Y; Gong YI; He J; Chen X
Biomed Rep; 2015 Mar; 3(2):235-241. PubMed ID: 26075077
[TBL] [Abstract][Full Text] [Related]
2. Metformin Use and Lung Cancer Risk in Diabetic Patients: A Systematic Review and Meta-Analysis.
Yao L; Liu M; Huang Y; Wu K; Huang X; Zhao Y; He W; Zhang R
Dis Markers; 2019; 2019():6230162. PubMed ID: 30881522
[TBL] [Abstract][Full Text] [Related]
3. Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: a systematic review and meta-analysis.
Wang Z; Lai ST; Xie L; Zhao JD; Ma NY; Zhu J; Ren ZG; Jiang GL
Diabetes Res Clin Pract; 2014 Oct; 106(1):19-26. PubMed ID: 24837144
[TBL] [Abstract][Full Text] [Related]
4. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
5. Metformin and breast cancer risk: a meta-analysis and critical literature review.
Col NF; Ochs L; Springmann V; Aragaki AK; Chlebowski RT
Breast Cancer Res Treat; 2012 Oct; 135(3):639-46. PubMed ID: 22847511
[TBL] [Abstract][Full Text] [Related]
6. Metformin and sulfonylureas in relation to cancer risk in type II diabetes patients: a meta-analysis using primary data of published studies.
Thakkar B; Aronis KN; Vamvini MT; Shields K; Mantzoros CS
Metabolism; 2013 Jul; 62(7):922-34. PubMed ID: 23419783
[TBL] [Abstract][Full Text] [Related]
7. Anti-diabetic medications do not influence risk of lung cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Nie SP; Chen H; Zhuang MQ; Lu M
Asian Pac J Cancer Prev; 2014; 15(16):6863-9. PubMed ID: 25169538
[TBL] [Abstract][Full Text] [Related]
8. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
[TBL] [Abstract][Full Text] [Related]
9. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemic agents and incidence of pancreatic cancer in diabetic patients: a meta-analysis.
Zhao Z; He X; Sun Y
Front Pharmacol; 2023; 14():1193610. PubMed ID: 37497113
[No Abstract] [Full Text] [Related]
11. Metformin improves survival in lung cancer patients with type 2 diabetes mellitus: A meta-analysis.
Zeng S; Gan HX; Xu JX; Liu JY
Med Clin (Barc); 2019 Apr; 152(8):291-297. PubMed ID: 30173870
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic Medications and the Risk of Endometrial Cancer in Patients.
Tian J; Liang Y; Qu P
Gynecol Obstet Invest; 2019; 84(5):455-462. PubMed ID: 30808843
[TBL] [Abstract][Full Text] [Related]
13. Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.
Decensi A; Puntoni M; Goodwin P; Cazzaniga M; Gennari A; Bonanni B; Gandini S
Cancer Prev Res (Phila); 2010 Nov; 3(11):1451-61. PubMed ID: 20947488
[TBL] [Abstract][Full Text] [Related]
14. The association between metformin therapy and risk of gynecological cancer in patients: Two meta-analyses.
Wen Q; Zhao Z; Wen J; Zhou J; Wu J; Lei S; Miao Y
Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():33-41. PubMed ID: 31009857
[TBL] [Abstract][Full Text] [Related]
15. Metformin, other antidiabetic drugs, and endometrial cancer risk: a nested case-control study within Italian healthcare utilization databases.
Franchi M; Asciutto R; Nicotra F; Merlino L; La Vecchia C; Corrao G; Bosetti C
Eur J Cancer Prev; 2017 May; 26(3):225-231. PubMed ID: 27222938
[TBL] [Abstract][Full Text] [Related]
16. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.
Zhou XL; Xue WH; Ding XF; Li LF; Dou MM; Zhang WJ; Lv Z; Fan ZR; Zhao J; Wang LX
Oncotarget; 2017 Aug; 8(33):55622-55631. PubMed ID: 28903449
[TBL] [Abstract][Full Text] [Related]
17. Metformin Use Is Associated with Decreased Mortality in COVID-19 Patients with Diabetes: Evidence from Retrospective Studies and Biological Mechanism.
Poly TN; Islam MM; Li YJ; Lin MC; Hsu MH; Wang YC
J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441802
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis.
Tian RH; Zhang YG; Wu Z; Liu X; Yang JW; Ji HL
Clin Transl Oncol; 2016 Jun; 18(6):641-9. PubMed ID: 26459254
[TBL] [Abstract][Full Text] [Related]
19. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.
Zhang ZJ; Bi Y; Li S; Zhang Q; Zhao G; Guo Y; Song Q
Am J Epidemiol; 2014 Jul; 180(1):11-4. PubMed ID: 24920786
[TBL] [Abstract][Full Text] [Related]
20. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
